Novozymes’ $12.3 Billion Merger with Chr. Hansen

Simpson Thacher represented Gordon Dyal & Co. in the transaction, while Davis Polk and Plesner advised Novozymes. Kromann Reumert has advised Novo Holdings and the Novo…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here